Baker Bros. Advisors LP Dice Therapeutics, Inc. Transaction History

Baker Bros. Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $4.52 Million - $5.61 Million	173,579 Added 20.13%	1,035,786 $29.7 Million
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $5.42 Million - $11.6 Million	273,972 Added 46.58%	862,207 $26.9 Million
Q3 2021 Nov 15, 2021	BUY	$31.92 - $37.0 $18.8 Million - $21.8 Million	588,235 New	588,235 $19.3 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.